LAMTOR5 and breast carcinoma: Additionally, although the function of HBXIP in GC was ambiguous previously, recent research has shown that HBXIP can promote breast cancer development via two mechanisms, one is based on activation of S100A4 expression by binding to its promoter and the other is fundamental to inducing the PTEN/PI3K/AKT signaling pathway [28].